MADISON (WKOW) — A former Badger hockey player is getting into the business of CBD.
Adam Burish, the former Wisconsin and NHL hockey player (and current hockey television analyst), has a new side project. The Madison native is also the vice president of development for Nasadol, a first-on-the-market nasal spray containing CBD, or cannabidiol. The product claims to treat anxiety and manage pain.
“I wanted to get this into athletes’ hands because I saw what it can do to help,” said Burish. “When I played I had 13 surgeries in 10 years. So, I took pills. I took a lot of pain killers. I took a lot of anti-inflammatories. I took a lot of sleeping pills … I took a lot. And in the two years since I retired, I haven’t taken a Tylenol.”
Nasadol is meant to be a new alternative to prescripton and over-the-counter medications.
“Thats what was exciting to me — it’s helping people, and it’s getting people off all that crap,” said Burish. “Those pills that people are taking linger. They’re addictive, too.”
Burish says because the product is inhaled through the nose, it goes straight into the bloodstream. So it’s quicker.
Dr. David Galbis-Reig, the Medical Director of Addiction Services at Ascension All Saints Hospital says because Nasadol doesn’t filter through the liver, the company would use a lower dosage of CBD in their product.
“So I can’t speak to whether it’s as effective or equally effective to what an oral will be,” said Galbis-Reig.
Galbis-Reig is not affiliated with Nasadol. He says it’s a good sign the product is labeled, explaining its dosage.
“If (a CBD product) has no label, there’s no legal requirement to actually contain any CBD,” said Galbis-Reig. “So when you are buying CBD products, you should buy a product that has a label that says specifically what’s in the bottle.”
Galbis-Reig says there are 137 ongoing studies to see if CBD works for a number of different conditions, including: anxiety, post-traumatic stress disorder, inflammation, arthritis, treating addiction and other uses.